Capital Investment Counsel, LLC

Position in LLY — ELI LILLY & Co

CIK 2033609 DENVER, CO

Position in LLY

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$3,520,327

+$817,123 QoQ

Shares Held

2,935

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.88%

of 13F equity value

Holder Rank

#1,994

of 4,605 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. LLY ranks #4 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	49,388	$12,427,996
2	AMGN	Amgen Inc	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc.	49,570	$6,262,673
4	LLY	ELI LILLY & Co This page	2,935	$3,520,327
5	JNJ	Johnson & Johnson	1,290	$327,621
6	MRK	Merck & Co., Inc.	2,041	$262,268

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,520,327	2,935	-0.1%	Shares	Sole	2026-07-15
2026-03-31	$2,703,204	2,939	-6.1%	Shares	Sole	2026-04-23
2025-12-31	$3,364,823	3,131	+5.0%	Shares	Sole	2026-02-02
2025-09-30	$2,275,266	2,982	+0.8%	Shares	Sole	2025-11-06
2025-06-30	$2,305,849	2,958	+0.4%	Shares	Sole	2025-08-01
2025-03-31	$2,432,304	2,945	+0.5%	Shares	Sole	2025-05-15
2024-12-31	$2,261,188	2,929	-0.2%	Shares	Sole	2025-01-23
2024-09-30	$2,601,119	2,936	+0.8%	Shares	Sole	2024-11-12
2024-06-30	$2,636,466	2,912	-0.5%	Shares	Sole	2024-08-14
2024-03-31	$2,277,088	2,927	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.